Education
About Us
Working with TipRanks
Follow Us
Carmat SA (FR:ALCAR)
:ALCAR
ALCAR Stock Chart & Stats
€0.10
€0.05(4.49%)
At close: 4:00 PM EST
€0.10
€0.05(4.49%)
Day’s Range― - ―
52-Week Range€0.09 - €1.25
Previous CloseN/A
Volume424.11K
Average Volume (3M)288.93K
Market Cap
€6.35M
Enterprise Value€116.94M
Total Cash (Recent Filing)€4.70M
Total Debt (Recent Filing)€57.80M
Price to Earnings (P/E)―
Beta2.03
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding64,254,005
10 Day Avg. Volume0
30 Day Avg. Volume288,932
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)-0.49
Price to Sales (P/S)3.55
P/FCF Ratio-0.55
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
International ExpansionData from the EFICAS study could be used to secure reimbursement for Aeson in France and help drive international adoption.
Regulatory ProgressThe company is in final stage of discussion with the FDA to obtain authorization to start the second cohort of the early feasibility study.
Sales GrowthManagement expects continued sales growth in European countries and sales in 2025 to double compared to sales in 2024.
Bears Say
Clinical And Regulatory RisksRisks include failure of TAH in clinical trials, failure to secure regulatory approval, and failure to achieve commercial success due to market size, penetration rate, and competition.
Financing NeedsThe company’s current cash runway is to the end of May 2025 and is actively exploring other financing solutions to extend its cash runway.
ALCAR FAQ
What was Carmat SA’s price range in the past 12 months?
Carmat SA lowest stock price was €0.09 and its highest was €1.25 in the past 12 months.
What is Carmat SA’s market cap?
Carmat SA’s market cap is €6.35M.
When is Carmat SA’s upcoming earnings report date?
Carmat SA’s upcoming earnings report date is Feb 18, 2026 which is in 66 days.
How were Carmat SA’s earnings last quarter?
Currently, no data Available
Is Carmat SA overvalued?
According to Wall Street analysts Carmat SA’s price is currently Overvalued.
Does Carmat SA pay dividends?
Carmat SA does not currently pay dividends.
What is Carmat SA’s EPS estimate?
Carmat SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Carmat SA have?
Carmat SA has 64,254,005 shares outstanding.
What happened to Carmat SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Carmat SA?
Currently, no hedge funds are holding shares in FR:ALCAR
Company Description
Carmat SA
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.
Technical Analysis
Theraclion SA
―
Ikonisys SA
―
Euromedis Groupe SA
―
Affluent Medical SA
―
Implanet SA
―